TrialJournal of nuclear medicine : official publication, Society of Nuclear Medicine2012

Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer.

Philip J Saylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.